Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial

References

• Wessel G, Zarko A, Peter von D, et al. Sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction – a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis. Received 2013 Oct 30; Accepted 2014 Feb 27.
   Google Scholar
• Lee MJ, Conner EL, Charafeddine L, et al. A critical birth weight and other determinants of survival for infants with severe intrauterine growth restriction. Ann N Y Acad Sci. 2001;943:326–339.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006;195(6):1557–1563.
   PubMed Web of Science ®Google Scholar
• Lyall F. Development of the utero-placental circulation: the role of carbon monoxide and nitric oxide in trophoblast invasion and spiral artery transformation. Microsc Res Tech. 2003;60(4):402–411.
   PubMed Web of Science ®Google Scholar
• Andrea L, John K, Robert G, et al. Intrauterine growth restriction: screening, diagnosis, and management. Vol 295. 2013.
   Google Scholar
• Alberry M, Soothill P. Management of fetal growth restriction. Arch Dis Child Fetal Neonatal Ed. 2007;92(1): F62–FF67.
   PubMed Web of Science ®Google Scholar
• Bell AW, Ehrhardt RA. Regulation of placental nutrient transport and implications for fetal growth. Nutr Res Rev. 2002;15(2):211–230.
   PubMed Web of Science ®Google Scholar
• Wu G, Pond WG, Flynn SP, et al. Maternal dietary protein deficiency decreases nitric oxide synthase and ornithine decarboxylase activities in placenta and endometrium of pigs during early gestation. J Nutr. 1998;128(12):2395–2402.
   PubMed Web of Science ®Google Scholar
• Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338(11):701–705.
   PubMed Web of Science ®Google Scholar
• Mardones-Santander DF, Rosso DP, Uiterwaal D, et al. Nutritional interventions to prevent intrauterine growth retardation: evidence from randomized controlled trials. Eur J Clin Nutr. 1999;53(12):970–972.
   PubMed Web of Science ®Google Scholar
• Gülmezoglu M, de Onis M, Villar J. Effectiveness of interventions to prevent or treat impaired fetal growth. Obstet Gynecol Surv. 1999;54(Suppl):58–68.
   Google Scholar
• Neilson JP, Alfirevic Z. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev. 2000;2(2):CD000073.
   Google Scholar
• Takagi Y, Nikaido T, Toki T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch. 2004;444(1):49–55.
   PubMed Web of Science ®Google Scholar
• Miller SL, Loose JM, Jenkin G, et al. The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus. Am J Obstet Gynecol. 2009;200(1):102.e1–102.e7.
   PubMed Web of Science ®Google Scholar
• Nanetti L, Giannubilo SR, Raffaelli F, et al. Nitric oxide and peroxynitrite platelet levels in women with small-for-gestational-age fetuses. BJOG. 2008;115(1):14–21.
   PubMed Web of Science ®Google Scholar
• Wareing M, Myers JE, O’Hara M, et al. Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2006;127(1):41–49.
   PubMed Web of Science ®Google Scholar
• Rosana G, Lawrence J, Alvarez A, et al. Effect of sildenafil citrate on intraocular pressure and blood pressure in human volunteers. Exp Eye Res. 2011;93(1):103–107.
   PubMed Web of Science ®Google Scholar
• Von Dadelszen P, Dwinnell S, Magee LA, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG. 2011;118(5):624–628.
   PubMed Web of Science ®Google Scholar
• Brown HL, Miller JM Jr., Gabert HA, et al. Ultrasonic recognition of the small-for-gestational-age fetus. Obstet Gynecol. 1987;69(4):631–635.
   PubMed Web of Science ®Google Scholar
• Brackley KJ. Intrauterine growth restriction: aetiology and management. Obstet Gynaecol. 2001;3(4):222.
   Google Scholar
• Quinton A, Cook C, Peek M. The prediction of the small for gestational age fetus with the head circumference to abdominal circumference (HC/AC) ratio: a new look at an old measurement. Sonography. 2015;2(2):27–31.
   Google Scholar
• Lessoway VA, Schulzer M, Wittmann BK, et al. Ultrasound Fetal Biometry charts for a North American Caucasian population. J Clin Ultrasound. 1998;26(9):433–453.
   PubMed Web of Science ®Google Scholar
• Cole TJ, Hey E, Richmond S. The PREM score: a graphical tool for predicting survival in very preterm births. Arch Dis Child Fetal Neonatal Ed. 2010;95(1):F14–F19.
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists. Green top guideline no 31. Royal College of Obstetricians and Gynaecologists; 2014.
   Google Scholar
• Khanduri S, Parashari UC, Bashir S, et al. Comparison of diagnostic efficacy of umbilical artery and middle cerebral artery waveform with color Doppler study for detection of intrauterine growth restriction. J Obstet Gynecol India. 2013;63(4):249–255.
   PubMedGoogle Scholar
• Arduini D, Rizzo G. Prediction of fetal outcome in small for gestational age fetuses: comparison of Doppler measurements obtained from different fetal vessels. J Perinat Med. 1992;20(1):29–38.
   PubMed Web of Science ®Google Scholar
• Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol. 2013;208(4):290.e1–290.e6.
   PubMed Web of Science ®Google Scholar
• Ramesar SV, Mackraj I, Gathiram P, et al. Sildenafil citrate improves fetal outcomes in pregnant, L-NAME treated, Sprague-Dawley rats. Eur J Obstet Gynecol Reprod Biol. 2010;149(1):22–26.
   PubMed Web of Science ®Google Scholar
• Ferreira E, Léveillée D, Iglesias MH, et al. Sildenafil use during pregnancy for intrauterine growth restriction: A case series. J Obstet Gynaecol Can. 2016;38:486.
   Google Scholar
• Premalatha HL, Raghupathia KMS, Srinivas DNB, et al. Study of effect of sildenafil citrate in pregnant women with IUGR/oligohydramnios. Int J Reprod Contracept Obstet Gynecol. 2016;5(9):3094–3097.
   Google Scholar
• Dastjerdi MV, Hosseini S, Bayani L. Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. J Res Med Sci. 2012;17(7):632–636.
   PubMed Web of Science ®Google Scholar
• Ganzevoort W, Alfirevic Z, von Dadelszen P, et al. STRIDER: sildenafil Therapy in Dismal prognosis Early-onset intrauterine growth Restriction – a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis. Syst Rev. 2014;3:23.
   PubMedGoogle Scholar
• Wareing M, Myers JE, O’Hara M, et al. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab. 2005;90(5):2550–2555.
   PubMed Web of Science ®Google Scholar